Summary

The results of the multicenter TAXUS Liberté Post Approval Study [TL-PAS] are discussed in this article. Patients randomized in this prospective open-label study were also participants in the Dual Antiplatelet Therapy Study. While the TL-PAS was not powered to show a difference in the end point analyses, the results from this specific trial were presented.